p300 regulates p53-dependent apoptosis after DNA damage in colorectal cancer cells by modulation of PUMA/p21 levels

Proceedings of the National Academy of Sciences of the United States of America

Volumn 101, Issue 19, 2004, Pages 7386-7391

  Gopalakrishna Iyer, N ^a,b   Chin, Suet Feung ^a   Ozdag, Hilal ^a   Daigo, Yataro ^a,c   Hu, De En ^a   Cariati, Massimiliano ^a   Brindle, Kevin ^a   Aparicio, Samuel ^a   Caldas, Carlos ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b SINGAPORE GENERAL HOSPITAL   (Singapore)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; E1A BINDING P300 NUCLEOPROTEIN; E1A PROTEIN; NUCLEOPROTEIN; PROTEIN MDM2; PROTEIN P21; PROTEIN P300; PROTEIN P53; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ACETYLATION; APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL FATE; COLORECTAL CANCER; CONTROLLED STUDY; CYTOSTASIS; DNA DAMAGE; HUMAN; HUMAN CELL; HUMAN TISSUE; MITOSIS INHIBITION; PRIORITY JOURNAL; PROTEIN DEFECT; PROTEIN STABILITY; ULTRAVIOLET RADIATION; XENOGRAFT;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BASE SEQUENCE; CELL LINE; COLORECTAL NEOPLASMS; DNA DAMAGE; DNA PRIMERS; DOXORUBICIN; HUMANS; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS P21(RAS); TRANS-ACTIVATORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 2442548716     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0401002101     Document Type: Article

References (44)

1. Prives, C. & Hall, P. A. (1999) J. Pathol. 187, 112-126.
2. Ko, L. J. & Prives, C. (1996) Genes Dev. 10, 1054-1072.
3. Sherr, C. J. & McCormick, F. (2002) Cancer Cell 2, 103-112.
4. Sherr, C. J. (1998) Genes Dev. 12, 2984-2991.
5. Fei, P. & El-Deiry, W. S. (2003) Oncogene 22, 5774-5783.
6. Seoane, J., Le, H. V. & Massague, J. (2002) Nature 419, 729-734.
7. Hemmati, P. G., Gillissen, B., von Haefen, C., Wendt, J., Starck, L., Guner, D., Dorken, B. & Daniel, P. T. (2002) Oncogene 21, 3149-3161.
8. Slee, E. A. & Lu, X. (2003) Toxicol. Lett. 139, 81-87.
9. Giles, R. H., Peters, D. J. & Breuning, M. H. (1998) Trends Genet. 14, 178-183.
10. Giordano, A. & Avantaggiati, M. L. (1999) J. Cell Physiol. 181, 218-230.
11. Goodman, R. H. & Smolik, S. (2000) Genes Dev. 14, 1553-1577.
12. Chan, H. M. & La Thangue, N. B. (2001) J. Cell Sci. 114, 2363-2373.
13. Somasundaram, K. & El-Deiry, W. S. (1997) Oncogene 14, 1047-1057.
14. Patel, D., Huang, S. M., Baglia, L. A. & McCance, D. J. (1999) EMBO J. 18, 5061-5072.
15. Grossman, S. R. (2001) Eur. J. Biochem. 268, 2773-2778.
16. Grossman, S. R., Perez, M., Kung, A. L., Joseph, M., Mansur, C., Xiao, Z. X., Kumar, S., Howley, P. M. & Livingston, D. M. (1998) Mol. Cell 2, 405-415.
17. Grossman, S. R., Deato, M. E., Brignone, C., Chan, H. M., Kung, A. L., Tagami, H., Nakatani, Y. & Livingston, D. M. (2003) Science 300, 342-344.
18. Barlev, N. A., Liu, L., Chehab, N. H., Mansfield, K., Harris, K. G., Halazonetis, T. D. & Berger, S. L. (2001) Mol. Cell 8, 1243-1254.
19. Espinosa, J. M. & Emerson, B. M. (2001) Mol. Cell 8, 57-69.
20. Sakaguchi, K., Herrera, J. E., Saito, S., Miki, T., Bustin, M., Vassilev, A., Anderson, C. W. & Appella, E. (1998) Genes Dev. 12, 2831-2841.
21. Dornan, D., Shimizu, H., Perkins, N. D. & Hupp, T. R. (2003) J. Biol. Chem. 278, 13431-13441.
22. Yuan, Z. M., Huang, Y., Ishiko, T., Nakada, S., Utsugisawa, T., Shioya, H., Utsugisawa, Y., Yokoyama, K., Weichselbaum, R., Shi, Y. & Kufe, D. (1999) J. Biol. Chem. 274, 1883-1886.
23. Waldman, T., Kinzler, K. W. & Vogelstein, B. (1995) Cancer Res. 55, 5187-5190.
24. Bunz, F., Dutriaux, A., Lengauer, C., Waldman, T., Zhou, S., Brown, J. P., Sedivy, J. M., Kinzler, K. W. & Vogelstein, B. (1998) Science 282, 1497-1501.
25. Chan, T. A., Hermeking, H., Lengauer, C., Kinzler, K. W. & Vogelstein, B. (1999) Nature 401, 616-620.
26. Javelaud, D. & Besancon, F. (2002) J. Biol. Chem. 277, 37949-37954.
27. Polyak, K., Waldman, T., He, T. C., Kinzler, K. W. & Vogelstein, B. (1996) Genes Dev. 10, 1945-1952.
28. Zhang, L., Yu, J., Park, B. H., Kinzler, K. W. & Vogelstein, B. (2000) Science 290, 989-992.
29. Yu, J., Wang, Z., Kinzler, K. W., Vogelstein, B. & Zhang, L. (2003) Proc. Natl. Acad. Sci. USA 100, 1931-1936.
30. Gayther, S. A., Batley, S. J., Linger, L., Bannister, A., Thorpe, K., Chin, S. F., Daigo, Y., Russell, P., Wilson, A., Sowter, H. M., et al. (2000) Nat. Genet. 24, 300-303.
31. Ozdag, H., Batley, S. J., Forsti, A., Iyer, N. G., Daigo, Y., Boutell, J., Arends, M. J., Ponder, B. A., Kouzarides, T. & Caldas, C. (2002) Br. J. Cancer 87, 1162-1165.
32. Langley, E., Pearson, M., Faretta, M., Bauer, U. M., Frye, R. A., Minucci, S., Pelicci, P. G. & Kouzarides, T. (2002) EMBO J. 21, 2383-2396.
33. Pfaffl, M. W. (2001) Nucleic Acids Res. 29, e45.
34. Vousden, K. H. (2002) Cancer Cell 2, 351-352.
35. Thomas, A. & White, E. (1998) Genes Dev. 12, 1975-1985.
36. Nakamura, S., Roth, J. A. & Mukhopadhyay, T. (2000) Mol. Cell. Biol. 20, 9391-9398.
37. Gartel, A. L. & Tyner, A. L. (2002) Mol. Cancer Ther. 1, 639-649.
38. Lee, C. W., Sorensen, T. S., Shikama, N. & La Thangue, N. B. (1998) Oncogene 16, 2695-2710.
39. Yu, J., Zhang, L., Hwang, P. M., Kinzler, K. W. & Vogelstein, B. (2001) Mol. Cell 7, 673-682.
40. Nakano, K. & Vousden, K. H. (2001) Mol. Cell 7, 683-694.
41. Lamb, J. R. & Friend, S. H. (1997) Nat. Med. 3, 962-963.
42. Waldman, T., Zhang, Y., Dillehay, L., Yu, J., Kinzler, K., Vogelstein, B. & Williams, J. (1997) Nat. Med. 3, 1034-1036.
43. Torrance, C. J., Agrawal, V., Vogelstein, B. & Kinzler, K. W. (2001) Nat. Biotechnol. 19, 940-945.
44. Kaeser, M. D. & Iggo, R. D. (2002) Proc. Natl. Acad. Sci. USA 99, 95-100.